Verinomics
New Haven, US · Founded 2016 · Delaware corporation · 2 known investors
Verinomics develops crop improvement technology by combining genomics, computational biology, and a transgene-free gene editing platform, with an AI-driven population genomics tool to identify high-value trait genes. It serves breeding programs, agricultural businesses, and research institutions focused on specialty and vegetatively propagated crops such as leafy greens.
AgTechAI & Machine LearningBiotech
Founders & leadership
Verinomics was founded in 2016 by Stephen Dellaporta.
SD
Stephen DellaportaFounder
CH
Christopher HeffelfingerNamed on SEC filing
MM
Mat MullerNamed on SEC filing
JZ
James ZhuNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$2M disclosed across 1 round · 2018
▶$2MraisedJan 2019 · 2 investors · OtherRule 506(b)
▶$2MraisedJan 2019 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Stephen DellaportaExecutive Officer, Director
- Christopher HeffelfingerExecutive Officer
- Mat MullerDirector
- James ZhuDirector
- Offering amount
- $3M
- Amount sold
- $2M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapGenomeweb32 shared keywordsGenomeWeb's Research Funding section publishes news coverage of research grants and government funding trends in genetics, genomics, and molecular diagnostics. It is an industry news publication serving researchers and organizations in the life sciences.
Genomics Plc16 shared keywordsGenomics builds a genotype-phenotype database and genetic risk-prediction tools used to support pharmaceutical drug discovery and clinical trials, as well as population health management and clinical decision support for healthcare providers. It serves life sciences companies and healthcare systems through its Life Sciences and Health & Wellness divisions.
Tagomics13 shared keywordsTagomics is focused on organ health, though the available page content does not provide enough detail about its products, technology, or business model.
Phenomic AI12 shared keywordsPhenomic AI is a biotech company developing therapies for solid tumors using a machine-learning-powered transcriptomics platform that analyzes single-cell RNA data to identify drug targets and understand tumor biology. The company develops antibody-based therapies informed by its analysis of cell-cell interactions in tumor microenvironments, with current programs targeting stromal and immune components of difficult-to-treat cancers.
Companies competing with Verinomics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Verinomics do?
- Verinomics develops crop improvement technology by combining genomics, computational biology, and a transgene-free gene editing platform, with an AI-driven population genomics tool to identify high-value trait genes. It serves breeding programs, agricultural businesses, and research institutions focused on specialty and vegetatively propagated crops such as leafy greens.
- Who founded Verinomics?
- Verinomics was founded by Stephen Dellaporta in 2016.
- Who are Verinomics's investors?
- Verinomics's investors include Cleveland Avenue, Fulcrum Global Capital.
- How much funding has Verinomics raised?
- Verinomics has disclosed $2M raised across 1 round.
- Where is Verinomics headquartered?
- Verinomics is headquartered in New Haven, US.